<DOC>
	<DOC>NCT00688064</DOC>
	<brief_summary>The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% / Benzoyl Peroxide (quoted as BPO) 2.5% Gel associated with Doxycycline Hyclate 100 mg Tablets compared to Adapalene 0.1% /Benzoyl Peroxide 2.5% Vehicle Gel associated with Doxycycline Hyclate 100 mg Tablets, in the treatment of severe acne vulgaris. The safety of the two treatment regimens will also be evaluated.</brief_summary>
	<brief_title>Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris</brief_title>
	<detailed_description>Further to this study, eligible Subjects with at least good Global Assessment of Improvement at Week 12 will be randomized in a maintenance study (SPR.29075)</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Male or female Subjects of any race, aged 12 to 35 years inclusive Subjects with severe facial acne (global severity score of 4) Subjects with a minimum of 20 inflammatory lesions (papules and pustules) on the face, excluding the nose Subjects with a minimum of 30 and a maximum of 120 noninflammatory lesions (open comedones and closed comedones) on the face, excluding the nose Subjects with more than 3 nodules or cysts on the face, Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, druginduced acne, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Acne</keyword>
</DOC>